Novel guanosine derivatives against Zika virus polymerase in silico
- PMID: 31436327
- PMCID: PMC7166851
- DOI: 10.1002/jmv.25573
Novel guanosine derivatives against Zika virus polymerase in silico
Abstract
The Zika virus (ZIKV) outbreak, which started in the year 2015, is considered the fastest and most widely spread outbreak reported for this flavivirus. The polymerase domain of the NS5 protein has been targeted in other viral infections and is recognized as a suitable target in ZIKV infection. Different novel modified compounds against ZIKV NS5 have been tested in silico. A few structures have been solved for ZIKV polymerase and deposited in the protein data bank website. Two of these solved structures (with a resolution of less than 1.9 A) are used in this study to test the binding of 74 novel compounds in silico. Molecular docking is used to quantify the binding affinities of ZIKV polymerase and compare it to the hepatitis C virus NS5B. A total of 19 novel compounds revealed results that are either similar to or better than the physiological molecule, guanosine triphosphate. Water molecules are found to facilitate the binding of the compounds to ZIKV RNA-dependent RNA polymerase (RdRp) structures. The presented 19 novel compounds represent good binders to ZIKV RdRp and could be suitable candidates for developing a new and effective anti-ZIKV polymerase nucleotide inhibitor.
Keywords: NS5; RNA-dependent RNA polymerase; Zika virus; drug-protein interaction; guanosine derivatives; molecular docking.
© 2019 Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures


Similar articles
-
Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.J Virol. 2020 Oct 14;94(21):e00794-20. doi: 10.1128/JVI.00794-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32796069 Free PMC article.
-
Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures.SAR QSAR Environ Res. 2018 May;29(5):409-418. doi: 10.1080/1062936X.2018.1454981. SAR QSAR Environ Res. 2018. PMID: 29652194
-
Binding of Nucleotide Inhibitors to the NS5 RdRp of the ZIKA Virus in the Replication Initiation State.Curr Med Chem. 2025;32(12):2460-2476. doi: 10.2174/0109298673259914231213052438. Curr Med Chem. 2025. PMID: 38347786
-
Structure and function of Zika virus NS5 protein: perspectives for drug design.Cell Mol Life Sci. 2018 May;75(10):1723-1736. doi: 10.1007/s00018-018-2751-x. Epub 2018 Feb 8. Cell Mol Life Sci. 2018. PMID: 29423529 Free PMC article. Review.
-
NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.J Med Virol. 2022 Feb;94(2):442-453. doi: 10.1002/jmv.27386. Epub 2021 Oct 20. J Med Virol. 2022. PMID: 34636434
Cited by
-
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective.Future Microbiol. 2022 Jul;17:755-762. doi: 10.2217/fmb-2022-0083. Epub 2022 May 5. Future Microbiol. 2022. PMID: 35510477 Free PMC article.
-
Chemoinformatic Design and Profiling of Derivatives of Dasabuvir, Efavirenz, and Tipranavir as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase and Methyltransferase.ACS Omega. 2022 Sep 6;7(37):33330-33348. doi: 10.1021/acsomega.2c03945. eCollection 2022 Sep 20. ACS Omega. 2022. PMID: 36157724 Free PMC article.
-
A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika.Virus Genes. 2022 Jun;58(3):151-171. doi: 10.1007/s11262-022-01898-5. Epub 2022 Apr 8. Virus Genes. 2022. PMID: 35394596 Review.
-
Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics.Iran J Basic Med Sci. 2021 Aug;24(8):1014-1022. doi: 10.22038/ijbms.2021.56250.12548. Iran J Basic Med Sci. 2021. PMID: 34804418 Free PMC article. Review.
-
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective.Future Virol. 2021 Jun:10.2217/fvl-2020-0233. doi: 10.2217/fvl-2020-0233. Epub 2021 Jul 13. Future Virol. 2021. PMID: 34290822 Free PMC article.
References
-
- MacNamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg. 1954;48(2):139‐145. - PubMed
-
- Dick GWA, Kitchen SF, Haddow AJ. Zika virus (I). Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46(5):509‐520. - PubMed
-
- Kuno G, Chang GJJ. Full‐length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007;152(4):687‐696. - PubMed
-
- Duffy MR, Chen T‐H, Hancock WT, et al. Zika virus outbreak on Yap Island, federated states of micronesia. N Engl J Med. 2009;360(24):2536‐2543. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials